Publicaciones en las que colabora con Mariano Provencio Pulla (15)

2012

  1. Durable complete remission of a brainstem glioma treated with a combination of bevacizumab and cetuximab

    Case Reports in Oncology, Vol. 5, Núm. 3, pp. 676-681

  2. Phase II trial of concomitant neoadjuvant chemotherapy with oxaliplatin and capecitabine and intensity-modulated radiotherapy (IMRT) in rectal cancer

    Journal of Gastrointestinal Cancer, Vol. 43, Núm. 4, pp. 553-561

  3. Prospective assessment of XRCC3, XPD and Aurora kinase A single-nucleotide polymorphisms in advanced lung cancer

    Cancer Chemotherapy and Pharmacology, Vol. 70, Núm. 6, pp. 883-890

  4. Trabectedin in patients with advanced non-small-cell lung cancer (NSCLC) with XPG and/or ERCC1 overexpression and BRCA1 underexpression and pretreated with platinum

    Lung Cancer, Vol. 76, Núm. 3, pp. 354-361

2011

  1. Single nucleotide polymorphisms in MDR1 gen correlates with outcome in advanced non-small-cell lung cancer patients treated with cisplatin plus vinorelbine

    Lung Cancer, Vol. 71, Núm. 2, pp. 191-198

2010

  1. Blood-based CHRNA3 single nucleotide polymorphism and outcome in advanced non-small-cell lung cancer patients

    Lung Cancer, Vol. 68, Núm. 3, pp. 491-497

  2. Experience with fulvestrant acetate in castration-resistant prostate cancer patients

    Annals of Oncology

2009

  1. Lung cancer and treatment in elderly patients: The Achilles Study

    Lung Cancer, Vol. 66, Núm. 1, pp. 103-106

  2. Management of platinum-resistant ovarian cancer with the combination of pemetrexed and gemcitabine

    Clinical and Translational Oncology, Vol. 11, Núm. 1, pp. 35-40

  3. Spanish Society of Medical Oncology consensus on the use of erythropoietic stimulating agents in anaemic cancer patients

    Clinical and Translational Oncology, Vol. 11, Núm. 11, pp. 727-736

2008

  1. Circulating tumor cells in breast cancer: Methodology and clinical repercussions

    Clinical and Translational Oncology, Vol. 10, Núm. 7, pp. 399-406

2007

  1. Customizing cisplatin based on quantitative excision repair cross-complementing 1 mRNA expression: A phase III trial in non-small-cell lung cancer

    Journal of Clinical Oncology, Vol. 25, Núm. 19, pp. 2747-2754

2004

  1. Ribonucleotide Reductase Messenger RNA Expression and Survival in Gemcitabine/Cisplatin-Treated Advanced Non-Small Cell Lung Cancer Patients

    Clinical Cancer Research, Vol. 10, Núm. 4, pp. 1318-1325

2003

  1. Cisplatin plus gemcitabine versus a cisplatin-based triplet versus nonplatinum sequential doublets in advanced non-small-cell lung cancer: A Spanish Lung Cancer Group phase III randomized trial

    Journal of Clinical Oncology, Vol. 21, Núm. 17, pp. 3207-3213

  2. Targeted therapy in combination with gemcitabine in non-small cell lung cancer

    Seminars in Oncology